δ-Opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats

Neuropharmacology

Volumn 39, Issue 2, 2000, Pages 161-171

  Becker, Chrystel ^a   Pohl, Michel ^a   Thiébot, Marie Hélène ^a   Collin, Elisabeth ^a,b   Hamon, Michel ^a   Cesselin, François ^a,b   Benoliel, Jean Jacques ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cholecystokinin like material; Frontal cortex; Microdialysis; Morphine tolerance; Opioid receptors; RT PCR

Indexed keywords

7 BENZYLIDENENALTREXONE; BINALTORPHIMINE; CHOLECYSTOKININ LIKE PEPTIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MORPHINE DERIVATIVE; NALOXONE; NALTRIBEN;

ANALGESIA; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; MALE; MICRODIALYSIS; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALGESICS, OPIOID; ANIMALS; CHOLECYSTOKININ; DRUG INTERACTIONS; DRUG TOLERANCE; MALE; MORPHINE; NARCOTIC ANTAGONISTS; PREFRONTAL CORTEX; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER;

EID: 0033988473     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00161-6     Document Type: Article

References (40)

1. Abdelhamid E.E., Sultana M., Portoghese P.S., Takemori A.E. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:1991;299-303.
2. 1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of freely moving rat. Neuropharmacology. 38:1999;525-532.
3. 2-Opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat. Synapse. 34:1999;47-54.
4. Beinfeld M.C. CCK biosynthesis and processing: recent progress and future challenges. Life Sci. 61:1997;2359-2366.
5. B receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro. Brain Res. 590:1992;255-262.
6. Benoliel J.-J., Collin E., Mauborgne A., Bourgoin S., Legrand J.C., Hamon M., Cesselin F. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Brain Res. 653:1994;81-91.
7. Benoliel J.-J., Mauborgne A., Bourgoin S., Legrand J.C., Hamon M., Cesselin F. Opioid control of in vitro release of cholecystokinin-like material from the rat substantia nigra. J. Neurochem. 58:1992;916-922.
8. Cesselin F. Opioid and anti-opioid peptides. Fundam. Clin. Pharmacol. 9:1995;409-433.
9. Chirgwin J.M., Przybyla A.E., McDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Crawley J.N. Comparative distribution of cholecystokinin and other neuropeptides. Ann. N.Y. Acad. Sci. 448:1985;1-8.
12. Crawley J.N. Cholecystokinin-dopamine interactions. Trends Pharmacol. Sci. 12:1991;232-236.
13. 8 in the posterior part of the nucleus accumbens. Brain Res. 617:1993;181-188.
14. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International Union of Pharmacology XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
15. Di Piero V., Ferracuti S., Sabatini U., Pantano P., Cruccu G., Lenzi G.L. A cerebral blood flow study on tonic pain activation in man. Pain. 56:1994;167-173.
16. Ding X.G., Fan S.G., Zhou J.P., Han J.S. Reversal of tolerance to morphine but no potentiation of morphine-induced analgesia by antiserum against cholecystokinin octapeptide. Neuropharmacology. 25:1986;1155-1160.
17. Dourish C.T., O'Neill M.F., Coughlan J., Kitchener S.J., Hawley D., Iversen S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 176:1990;35-44.
18. Fundytus M.E., Schiller P.W., Shapiro M., Weltrowska G., Coderre T.J. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP. Eur. J. Pharmacol. 286:1995;105-108.
19. Gall C., Lauterborn J., Burks D., Seroogy K. Co-localisation of enkephalin and cholecystokinin in discrete areas of rat brain. Brain Res. 403:1987;403-408.
20. 3H]DOPA in various regions of the rat brain. J. Neurochem. 13:1966;655-669.
21. 8 and of the CCK-B selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res. 628:1993;254-262.
22. Nevo I., Becker C., Hamon M., Benoliel J.-J. Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron. J. Neurochem. 66:1996;2041-2049.
23. 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for δ-opioid receptor heterogeneity. Neuroscience. 75:1996;917-926.
24. Panerai A.E., Rovati L.C., Cocco E., Sacerdote P., Mantegazza P. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin. Brain Res. 410:1987;52-60.
25. Paxinos P., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed:1986;Academic Press, Sydney.
26. Pohl M., Collin E., Benoliel J.J., Bourgoin S., Cesselin F., Hamon M. Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment. Neuropeptides. 21:1992;193-200.
27. Pu S., Zhuang H., Lu Z., Wu X., Han J. Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance. Mol. Brain Res. 21:1994;183-189.
28. Rattray M., de Belleroche J. Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone. Neuropeptides. 10:1987;189-200.
29. Rodriguez R.E., Sacristan M.P. In vivo release of CCK-8 from the dorsal horn of the rat: inhibition by DAGOL. FEBS Lett. 250:1989;215-217.
30. Roques B.P., Noble F. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction. Neurochem. Res. 21:1996;1397-1410.
31. Roques B.P., Noble F., Daugé V., Fournié-Zaluski M.C., Beaumont A. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45:1993;87-145.
32. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
33. 3H]pBC264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins. J. Neurochem. 59:1992;1805-1811.
34. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
35. Stinus L., Le Moal M., Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience. 37:1990;767-773.
36. Takemori A.E., Portoghese P.S. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-funaltrexamine-treated mice. J. Pharmacol. Exp. Ther. 243:1987;91-94.
37. Tang J., Chou J., Iadarola M., Yang H., Costa E. Proglumide prevents and curtails acute tolerance to morphine in rats. Neuropharmacology. 23:1984;715-718.
38. Tsubokawa T., Katayama Y., Ueno Y., Moriyasu N. Evidence for involvement of the frontal cortex in pain-related cerebral events in cats: increase in local cerebral blood flow by noxious stimuli. Brain Res. 217:1981;179-185.
39. Watkins L.R., Kinscheck I.B., Mayer D.J. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science. 224:1984;395-396.
40. Zimmerman D.M., Leander J.D. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J. Med. Chem. 33:1990;895-902.